Martin J Scurr
Overview
Explore the profile of Martin J Scurr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scurr M, Lippiatt G, Capitani L, Bentley K, Lauder S, Smart K, et al.
Nat Commun
. 2022 Sep;
13(1):5422.
PMID: 36130936
T cells specific for SARS-CoV-2 are thought to protect against infection and development of COVID-19, but direct evidence for this is lacking. Here, we associated whole-blood-based measurement of SARS-CoV-2-specific interferon-γ-positive...
2.
Tallantyre E, Scurr M, Vickaryous N, Richards A, Anderson V, Baker D, et al.
Mult Scler Relat Disord
. 2022 Jun;
64:103937.
PMID: 35700625
Background: People with MS treated with anti-CD20 therapies and fingolimod often have attenuated responses to initial COVID-19 vaccination. However, uncertainties remain about the benefit of a 3rd (booster) COVID-19 vaccine...
3.
Scurr M, Zelek W, Lippiatt G, Somerville M, Burnell S, Capitani L, et al.
Immunology
. 2021 Nov;
165(2):250-259.
PMID: 34775604
Accurate assessment of SARS-CoV-2 immunity is critical in evaluating vaccine efficacy and devising public health policies. Whilst the exact nature of effective immunity remains incompletely defined, SARS-CoV-2-specific T-cell responses are...
4.
Bradley R, Ponsford M, Scurr M, Godkin A, Jolles S
J Clin Immunol
. 2021 Oct;
42(1):32-35.
PMID: 34714497
No abstract available.
5.
Tallantyre E, Vickaryous N, Anderson V, Asardag A, Baker D, Bestwick J, et al.
Ann Neurol
. 2021 Oct;
91(1):89-100.
PMID: 34687063
Objective: The purpose of this study was to investigate the effect of disease modifying therapies on immune response to severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) vaccines in people with multiple...
6.
Thomson A, Bento D, Scurr M, Smart K, Somerville M, Keita A, et al.
Br J Cancer
. 2021 Mar;
124(9):1552-1555.
PMID: 33674735
Background: The T cell cytokine profile is a key prognostic indicator of post-surgical outcome for colorectal cancer (CRC). Whilst T1 (IFN-γ) cell-mediated responses generated in CRC are well documented and...
7.
Scurr M, Greenshields-Watson A, Campbell E, Somerville M, Chen Y, Hulin-Curtis S, et al.
Clin Cancer Res
. 2020 Mar;
26(13):3360-3370.
PMID: 32122920
Purpose: Broadly expressed, highly differentiated tumor-associated antigens (TAA) can elicit antitumor immunity. However, vaccines targeting TAAs have demonstrated disappointing clinical results, reflecting poor antigen selection and/or immunosuppressive mechanisms. Experimental Design:...
8.
Thomson A, Smart K, Somerville M, Lauder S, Appanna G, Horwood J, et al.
BMC Gastroenterol
. 2019 Jun;
19(1):98.
PMID: 31221083
Background: The relationship between intestinal epithelial integrity and the development of intestinal disease is of increasing interest. A reduction in mucosal integrity has been associated with ulcerative colitis, Crohn's disease...
9.
Besneux M, Greenshields-Watson A, Scurr M, MacLachlan B, Christian A, Davies M, et al.
Cancer Immunol Immunother
. 2018 Nov;
68(2):247-256.
PMID: 30406375
The oncofoetal antigen 5T4 is a promising T cell target in the context of colorectal cancer, as demonstrated by a recent clinical study where 5T4-specific T cell responses, induced by...
10.
Clement M, Marsden M, Stacey M, Abdul-Karim J, Gimeno Brias S, Costa Bento D, et al.
PLoS Pathog
. 2016 Dec;
12(12):e1006050.
PMID: 27926930
CD4+ T cells support host defence against herpesviruses and other viral pathogens. We identified that CD4+ T cells from systemic and mucosal tissues of hosts infected with the β-herpesviridae human...